£147.93

Convalescent Plasma and Other Antibody Therapies for Infectious Diseases: Lessons learned from COVID-19 and Future Prospects: 443 (Current Topics in Microbiology and Immunology, 443)

Name: Convalescent Plasma and Other Antibody Therapies for Infectious Diseases: Lessons learned from COVID-19 and Future Prospects: 443 (Current Topics in Microbiology and Immunology, 443)
Brand: Unknown
Price: 147.93 GBP
Availability: InStock

Diseases & Disorders

Price data last checked 124 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

This is the most expensive it has ever been. Walk away.

£148 today · previous high £148 · all-time low £147

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 65 days • 65 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 65 days • 2 price levels

Days at Price

Current Price

Price Analysis

Most common price: £148 (61 days, 93.8%)

Price range: £147 - £148

Price levels: 2 different prices over 65 days

Description

This volume reviews key scientific principles and practices of passive antibody therapy for the treatment of infectious diseases. The main focus is on convalescent plasma, which is the most useful therapeutic option early in an epidemic, and may be especially important in low- and middle-income countries. The book’s first section reviews the history of passive antibody therapies prior to the COVID pandemic, while the second section assesses convalescent plasma use during the COVID pandemic including evidence for safety and effectiveness, factors affecting efficacy, and the importance of convalescent plasma treatment of COVID-19 infections in the immunosuppressed. This section also addresses the roles played in the pandemic by monoclonal antibodies and hyperimmune globulins. Section three discusses the logistics of retrieving, storing and delivering convalescent plasma for therapy, and section four considers the role of passive antibody therapies in the event of a new pandemic involving an unknown microbial pathogen. In March 2020 the editors of this volume founded the national COVID-19 convalescent plasma project (ccpp19), an association of academic physicians organized to investigate the safety and effectiveness of convalescent plasma and to facilitate access to its use in the treatment of this new international pandemic. Since that time, the project has produced more than 100 papers on almost every aspect of convalescent plasma usage in COVID-19 – treatment protocols, randomized trials, considerations of safety, conditions required for effectiveness, variability in use geographically and over time, application to vulnerable populations, regulatory issues, impact on overall COVID-19 mortality in the US and much else. At the same time, another form of antibody therapy – monoclonal antibodies – was being shown effective for out-patient use in COVID-19, confirming the principle of the value of antibody therapy in the early stages of disease, but lost effectiveness with viral mutation. A third form of antibody therapy – hyperimmune globulin, a preventive therapy with an excellent historical record of efficacy in several infectious diseases - holds great potential but was not effectively developed for COVID-19. This edited work brings together the central findings gained over the past years about passive antibody use and serves as an indispensable guide to best practices in the use of antibody therapies.

Product Specifications

Format: hardcover
ASIN: 3031871669
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Internal Medicine > Diseases & Disorders
Domain: Amazon UK
Release Date: 17 October 2025
Listed Since: 07 February 2025

Barcode

No barcode data available

Convalescent Plasma and Other Antibody Therapies for Infectious Diseases: Lessons learned from COVID-19 and Future Prospects: 443 (Current Topics in Microbiology and Immunology, 443)

This is the most expensive it has ever been. Walk away.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Natural Antibodies: Methods and Protocols: 1643 (Methods in Molecular Biology, 1643)

Humana Antibody Methods and Protocols: 901 (Methods in Molecular Biology)

Diagnostic and Therapeutic Antibodies: 40 (Methods in Molecular Medicine, 40)

Antibodies: Volume 2: Novel Technologies and Therapeutic Use

Human Monoclonal Antibodies: Methods and Protocols: 1060 (Methods in Molecular Biology, 1060)

Detection of SARS-CoV-2 Antibodies in Diagnosis and Treatment of COVID-19, An Issue of the Clinics in Laboratory Medicine: Volume 42-1 (The Clinics: Internal Medicine, Volume 42-1)

Peptide Antibodies: Methods and Protocols: 1348 (Methods in Molecular Biology, 1348)

Antibodies in Viral Infection: 260 (Current Topics in Microbiology and Immunology, 260)

Therapeutic Antibodies: Methods and Protocols: 2313 (Methods in Molecular Biology, 2313)

Antibody Engineering Volume 2

Human Antibody Therapeutics For Viral Disease: 317 (Current Topics in Microbiology and Immunology, 317)

Immunology & Serology in Laboratory Medicine

The Antibodies: 7

Complement in Health and Disease: 20 (Immunology and Medicine)

Human Monoclonal Antibodies: Methods and Protocols: 1060 (Methods in Molecular Biology, 1060)

Humana Immune Receptors: Methods and Protocols 748 Book

Introduction to Antibody Engineering (Learning Materials in Biosciences)

Antibody Engineering: Methods and Protocols: 248 (Methods in Molecular Biology, 248)

Recombinant Antibodies for Immunotherapy

Monoclonal Antibodies (Springer Lab Manuals)

The Complement System: Innovative Diagnostic and Research Protocols: 2227 (Methods in Molecular Biology, 2227)

Humana Antibody Engineering: Methods and Protocols 1827

Development of Antibody-Based Therapeutics: Translational Considerations & Challenges

Immunochemical Protocols: 295 (Methods in Molecular Biology, 295)